Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients

详细信息    查看全文

• 作者：Pamela Samson^a ; Kathleen Keogan^b ; Traves Crabtree^a ; Graham Colditz^c ; Stephen Broderick^d ; Varun Puri^a ; Bryan Meyers^a ; ^{meyersb@wudosis.wustl.edu}
• 关键词：Lung cancer ; Surgery ; Stereotactic body radiation therapy ; Clinical trials
• 刊名：Lung Cancer
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：103
• 期：Complete
• 页码：6-10
• 全文大小：420 K
• 卷排序：103

文摘

Trials that close with poor accrual in Stage I NSCLC have variable survival rates. Simulating trial accrual goals have survival results similar to clinical experience. Conclusions for SBRT in operable Stage I NSCLC cannot be made from such trials.